Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21063134rdf:typepubmed:Citationlld:pubmed
pubmed-article:21063134lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0750952lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0087113lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:21063134lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:21063134pubmed:issue1-2lld:pubmed
pubmed-article:21063134pubmed:dateCreated2011-1-3lld:pubmed
pubmed-article:21063134pubmed:abstractTextThe purpose of this study was to elucidate the treatment efficacy and safety of gemcitabine monotherapy, and to identify prognostic factors in patients with advanced biliary tract cancer receiving this therapy.lld:pubmed
pubmed-article:21063134pubmed:languageenglld:pubmed
pubmed-article:21063134pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:citationSubsetIMlld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21063134pubmed:statusMEDLINElld:pubmed
pubmed-article:21063134pubmed:issn1423-0232lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:UenoHidekiHlld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:OkusakaTakuji...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:IkedaMasafumi...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:FuruseJunjiJlld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:ShimizuSatosh...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:KojimaYasushi...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:MorizaneChigu...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:KondoShunsuke...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:HagiharaAtsus...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:MitsunagaShui...lld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:NakachiKoheiKlld:pubmed
pubmed-article:21063134pubmed:authorpubmed-author:SuzukiEiichir...lld:pubmed
pubmed-article:21063134pubmed:copyrightInfoCopyright © 2010 S. Karger AG, Basel.lld:pubmed
pubmed-article:21063134pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21063134pubmed:volume79lld:pubmed
pubmed-article:21063134pubmed:ownerNLMlld:pubmed
pubmed-article:21063134pubmed:authorsCompleteYlld:pubmed
pubmed-article:21063134pubmed:pagination39-45lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:meshHeadingpubmed-meshheading:21063134...lld:pubmed
pubmed-article:21063134pubmed:year2010lld:pubmed
pubmed-article:21063134pubmed:articleTitleTreatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases.lld:pubmed
pubmed-article:21063134pubmed:affiliationDivision of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan. eisuzuki@ks.kyorin-u.ac.jplld:pubmed
pubmed-article:21063134pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21063134pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed